Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2015

Nov 13, 2015

5262_dirs_2015-11-13_4a4eebda-04b2-4265-ad11-4aa5ce29e08f.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7113F

GlaxoSmithKline PLC

13 November 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4 R(1)(c) GlaxoSmithKline plc ('GSK') was advised on 13 November 2015 of the following increase in the notional allocation of GSK American Depositary Shares ('ADSs') on 12 November 2015, at a price of $40.05 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401K plan:

Director Number of ADSs
Dr M Slaoui 24
Connected person Number of ADSs
Dr K Slaoui (Connected Person of Dr M Slaoui) 1

V A Whyte

Company Secretary

13 October 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSZXLFFEFFFFBX